ArticleInnovations in clinical neuroscience2019

Brexpiprazole as a New Serotonin-Dopamine Receptor Modulator: Considering the Clinical Relevance for Metabolic Parameters and Prolactin Levels.

Masaru Nakamura et al.PubMed ↗Full text ↗

No numbers read from the abstract.